2010年至2014年,Intra-Cellular公司实现资本市场四级跳,分别完成A轮融资、B轮融资、C轮融资以及在纳斯达克的IPO上市。按当时发行价计算,Intra-Cellular的估值约为5.25亿美元。 在产品研发方面,Intra-Cellular的核心产品为lumateperone(商品名:Caplyta)是一款首创的FIC小分子药物。其作用机制独特,能对多巴胺D1和D2受体...
etfs emerging markets etfs growth vs. value etfs bonds education podcasts videos investing groups explore investing groups portfolios find & compare stock screener all stocks top rated stocks top growth stocks top value stocks ...
The attempted assassination of Donald Trump on Saturday has boosted the former president's chances of a second term in office. ^IN Latest Stock Market News & Data Jul 15, 2024 4:53 PM EDT Forget Nvidia, it may be time to buy small-cap stocks Smaller stocks are starting to outperform lar...
Bid Price and Ask Price The bid & ask refers to the price that an investor is willing to buy or sell a stock. The bid is the highest amount that a buyer is currently willing to pay, whereas the ask is the lowest amount that a seller is currently willing to sell. Th...
Johnson & JohnsonJNJ:NYSE RT Quote|Last NASDAQ LS, VOL From CTA|USD After Hours:Last |03/14/25 EDT 162.59-0.21(-0.13%) Volume 260,075 Close 162.81-0.18(-0.11%) Volume 5,962,774 52 week range 140.68-169.99 SummaryNewsProfileEarningsPeersFinancialsOptionsOwnership ...
Johnson & JohnsonJNJ:NYSE RT Quote|Last NYSE Arca, VOL From CTA|USD After Hours:Last |7:59 AM EDT 162.83-0.00(-0.00%) Volume 5,039 Close 162.84+0.04(+0.02%) Volume 5,642,349 52 week range 140.68-169.99 SummaryNewsProfileEarningsPeersFinancialsOptionsOwnership ...
Johnson & Johnson (NYSE:JNJ – Get Rating) has been assigned a consensus recommendation of "Moderate Buy" from the seventeen brokerages that are currently covering the stock, Marketbeat reports. Eight analysts have rated the stock with a hold rating, six have given a buy rating and one ...
Use Futu NiuNiu to view Johnson & Johnson (JNJ)'s stock price, real-time quotes, latest news, historical trend charts, financial information and quotes.
There’s nothing I can see that should stop you from buying JNJ stock. It’s a Sell Of the17 analysts covering JNJ, only one rate it “underweight” or “sell” while 10 believes it’s a “buy,” two more have it “overweight,” and four rate it a “hold....
Johnson & JohnsonJNJ:NYSE RT Quote|Last NYSE Arca, VOL From CTA|USD After Hours:Last |6:19 PM EDT 163.00+0.16(+0.10%) Volume 1,012,955 Close 162.84+0.04(+0.02%) Volume 5,642,349 52 week range 140.68-169.99 SummaryNewsProfileEarningsPeersFinancialsOptionsOwnership ...